Firefly Neuroscience Sees Stock Surge Following Warrant Exercise
Market Chameleon (Fri, 21-Feb 3:28 AM ET)
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
Globe Newswire (Fri, 21-Feb 8:00 AM ET)
Firefly Neuroscience Accepted into NVIDIA Connect Program
Globe Newswire (Tue, 11-Feb 7:45 AM ET)
Globe Newswire (Fri, 7-Feb 7:30 AM ET)
Globe Newswire (Fri, 24-Jan 9:00 AM ET)
Globe Newswire (Tue, 14-Jan 7:45 AM ET)
Business Wire (Fri, 10-Jan 8:00 AM ET)
Firefly Neuroscience Closes on Financing of up to $12.4 Million
Globe Newswire (Tue, 31-Dec 9:00 AM ET)
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders.
Firefly Neuroscience trades on the NASDAQ stock market under the symbol AIFF.
As of March 5, 2025, AIFF stock price declined to $4.07 with 599,740 million shares trading.
AIFF has a beta of 6.59, meaning it tends to be more sensitive to market movements. AIFF has a correlation of 0.20 to the broad based SPY ETF.
AIFF has a market cap of $32.85 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that AIFF belongs to (by Net Assets): VXF.
AIFF support price is $3.47 and resistance is $4.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AIFF shares will trade within this expected range on the day.